Key Sessions
Giancarlo Francese, PhD
A Universal Blueprint for Affordability: Lessons in Formulation and Packaging for Global Health Equity
Gates Foundation
Gene Malin, PhD
AI for Rapid Response: How Digital Technologies can Accelerate Vaccine Development
CEPI
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Clear
Showing 1 of 1 Streams
Downstream Processing
10:45 - 10:50
Chairperson's Opening Remarks
- Alois Jungbauer - Professor, Dept. of Biotechnology, BOKU University
10:50 - 11:20
Efficient host cell protein clearance: A study of membrane adsorbers and resins in biopharmaceutical processes
- Ernest Šprager - Expert Science & Technology, DSPD, Novartis Technical Research & Development
11:20 - 11:50
Beyond Protein A: Building a Non-Affinity Purification Toolbox for the Post-mAb Era
- Johannes Buyel - Head of Department, BOKU, Austria
Showing 1 of 1 Streams
Downstream Processing
13:40 - 13:45
Chairperson's Opening Remarks
- Alois Jungbauer - Professor, Dept. of Biotechnology, BOKU University
13:45 - 14:15
Magnetic Beads for Cell Separation and Purification: A Scalable, Column-Free Approach
- Sebastian Schwaminger - Associate Professor, Medical University of Graz
Showing 1 of 1 Streams
Downstream Processing
16:00 - 16:30
[Plenary hosted in Cell Culture & Upstream Processing] The Midstream Bottleneck: Novel Culture and Filtration Strategies for Advanced Modalities
- Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
16:30 - 17:00
[Plenary hosted in Cell Culture & Upstream Processing] PANEL DISCUSSION: Collaboration - The Future Role Model for Resilient Biologics Supplies
- Uwe Buecheler - Chairman of the Board, Biopharma Cluster South Germany
- Ulrich Rümenapp - Senior Biotech Program Lead, Bayer AG
- Melanie Dannemeyer - Associate Director, Biopharma Drug Substance, AstraZeneca
- Christian Eckermann - Corp. SVP BioPharma Network, Boehringer Ingelheim International GmbH
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
